Cytek Biosciences is a cell analysis solutions company developing cell analysis tools by using technical approaches. Co. has developed and manufactured its full spectrum flow cytometry platform. Co.'s main instruments, the Aurora and Northern Lights systems, are the full spectrum flow cytometers able to deliver cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Co.'s Full Spectrum Profiling platform includes instruments, reagents, software, and services to provide an integrated suite of solutions for its customers. We show 11 historical shares outstanding datapoints in our CTKB shares outstanding history coverage, used to compute CTKB market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing CTKB market cap history over the course of time is important for investors
interested in comparing CTKB's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of CTKB versus a peer is one thing; comparing
CTKB market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like CTKB can fluctuate over the course of history.
With this page we aim to empower investors researching CTKB by allowing them to research the CTKB market cap history. |
Free CTKB Email Alerts:
Video: The Importance of Market Cap
